Historical Development of Progesterone Therapy

  • Ronald V. Norris


The crash of the stockmarket was not the only momentous event of 1929. It was also an exciting year in our knowledge of female repro ductive endocrinology. The use of the experimental method as a means of elucidating the origin and functional significance of the ovarian luteal body stems only from the beginning of this century. Prior to the turn of the century, there were approximately 2,000 years of curiosity, erroneous observation, and unfounded speculations embodied in the dialectical approach (Greep, 1977). One must keep in mind that the ovary had no known functional significance other than the production of ova until the works of Beard (1897), Prenant (1898), and Fraenkel (1903) were published. This is quite remarkable considering that the endocrine function of the testes had been established 50 years earlier (Berthold, 1849).


Menstrual Cycle Corpus Luteum Premenstrual Syndrome Reproductive Endocrinology Rhizopus Arrhizus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abplanalp, J. M., A. F. Donnelly, and R. M. Rose, 1979. Psychoendo-crinology of menstrual cycle, 1 Enjoyment of daily activities and moods. Psychosomatic Medicine 41 587–604.PubMedGoogle Scholar
  2. Albaux-Fernet, M. and G. Loublie, 1946. Seminar Hospital Paris 22 U87–U90.Google Scholar
  3. Allen, E. and E. A. Doisy, 1923. An ovarian hormone. A preliminary report on its localization, extraction, and partial purification and action in test animals. Journal of the American Medical Association 81 819–824.CrossRefGoogle Scholar
  4. Allen, W. M., 1939. Biochemistry of the corpus luteum hormone, proges terone. In E. Allen, C. H. Danforth, and E. A. Doisy (Eds.), Sex and Internal Secretions. Williams & Wilkins, Baltimore, MD, pp. 901–928.Google Scholar
  5. Allen, W. M., 1974. Recollections of my life with progesterone. Gynecological Investigations 5 142–182.CrossRefGoogle Scholar
  6. Allen, W. M. and G. W. Corner, 1929. Physiology of the corpus luteum IV. Proceedings of the Society for Experimental Biology and Medicine 27 403–405.Google Scholar
  7. Allen, W. M., A. Butenandt, G. W. Corner, and K. H. Slotta, 1935. Nomenclature of corpus luteum hormone. Science 82 153.PubMedCrossRefGoogle Scholar
  8. Anand, Kumar T. C., G.F.X. David, and V. Puri, 1977. Ovulation in rhesus monkeys suppressed by intranasal administration of progesterone and norethisterone. Nature 270 532–535.CrossRefGoogle Scholar
  9. Anderson, A. W. and J. F. Larsen, 1979. Bromocriptine in the treatment of premenstrual syndrome. Drugs 17 383–385.CrossRefGoogle Scholar
  10. Backstrom, T. and B. Mattsson, 1975. Correlation of symptoms in premenstrual tension to oestrogen and progesterone concentrations in blood plasma. Neuropsychobiology 1 80–86.PubMedCrossRefGoogle Scholar
  11. Backstrom, A. W., L. Wide, and R. Sodergard, 1976. FSH, LH, TeBG-capacity, estrogen and progesterone in women with premenstrual tension during the luteal phase. Journal of Steroid Biochemistry 7 473–476.PubMedCrossRefGoogle Scholar
  12. Bardin, C. W., E. Milgrom, and P. Mauvais-Jarvis (Eds.), 1983. Progesterone and Progestins. Raven Press, New York, NY.Google Scholar
  13. Beard, J., 1897. The Span of Gestation and the Cause of Birth. A Study of the Critical Period and Its Effects in Mammalia. Gustav Fischer, Jena, German Democratic Republic.Google Scholar
  14. Berthold, A. A., 1849. Transplantation der hoden. Archive Anatomie Physiologie und Wizzenschaft Medicine 16 42–46.Google Scholar
  15. Bickers, N. and M. Wood, 1951. Premenstrual tension Rational treatment. Texas Report on Biology and Medicine 9 406–419.Google Scholar
  16. Bullough, V. and M. Voght, 1973. Women, menstruation and nineteenth-century medicine. Bulletin of the History of Medicine 47 66–82.PubMedGoogle Scholar
  17. Butenandt, A. and U. Westphal, 1934. Uber die Darstellung des Corpus-luteum-Hormons aus Stigmastrin Die Konstition des Corpus-luteum-Hormons. Berichte Deutschen Chemische Gesellschaft 67 2085–2087.CrossRefGoogle Scholar
  18. Chez, R. A., 1978. Proceedings of the symposium Progesterone, Progestins, and Fetal Development. Fertility and Sterility 30 16–26.PubMedGoogle Scholar
  19. Clark, M. and D. Shapiro, 1981. The monthly syndrome. Newsweek, May 4, p. 74.Google Scholar
  20. Corner, G. W., 1928. The effect of very early ablation of the corpus luteum on embryos and uterus. American Journal of Physiology 86 74–81.Google Scholar
  21. Corner, G. W., 1974. The early history of progesterone. Gynecological Investigations 5 106.CrossRefGoogle Scholar
  22. Corner, G. W. and W. M. Allen, 1929. Physiology of the corpus luteum II. American Journal of Physiology 88 326–346.Google Scholar
  23. Dalton, K., 1959. Comparative trials of new oral progestagenic compounds in the treatment of the premenstrual syndrome. British Medical Journal 2 1307–1309.PubMedCrossRefGoogle Scholar
  24. Dalton, K., 1977. Premenstrual Syndrome and Progesterone Therapy. William Heinemann Medical Books, Ltd., London.Google Scholar
  25. Dalton, K., 1984. Premenstrual Syndrome and Progesterone Therapy (second edition). William Heinemann Medical Books, Ltd., London.Google Scholar
  26. Dejong, R., D. R. Rubinow, P. Roy-Byrne, M. C. Hoban, G. N. Grover, and R. M. Post, 1985. Premenstrual mood disorder and psychiatric illness. American Journal of Psychiatry 142 1359–1361.PubMedGoogle Scholar
  27. De Soldati, L., I. E. De Forteza, C. R. Pellegatta, and H. Cammarota, 1966. The antihypertensive action of progesterone. Cardiologia 48 489–503.PubMedCrossRefGoogle Scholar
  28. DeWees, W. P., 1847. A Treatise on the Disease of Females. Lea and Blanchard, Philadelphia, PA.Google Scholar
  29. Doisy, E. A., C. D. Veler, and S. Thayer, 1929. Folliculin from urine of pregnant women. American Journal of Physiology 90 392.Google Scholar
  30. Endicott, J. and U. Halbreich, 1982. Psychobiology of premenstrual change. Psychopharmacology Bulletin 18 109–112.Google Scholar
  31. Fernholz, E., 1934. Zur synthese des corpus-luteum-hormons. Berichte Deutschen Chemische Gesellschaft 67 1855–1862.CrossRefGoogle Scholar
  32. Food and Drug Administration, 1981. Safety and Efficacy of Progesterone and 17-Hydroxy progesterone for Treatment of Reproductive Disorders. Fertility and Maternal Health Drugs Advisory Committee. FDA, Rockville, MD, November.Google Scholar
  33. Food and Drug Administration Bulletin, 1982. Use of Approved Drugs for Unlabeled Indications. FDA, Rockville, MD, April 4–5.Google Scholar
  34. Fraenkel, L., 1903. Die function des corpus-luteum. Archive Gynakologischen 68 438–445.CrossRefGoogle Scholar
  35. Frank, R. T., 1929. The Female Sex Hormone. Charles C. Thomas, Baltimore, MD, p. 236.Google Scholar
  36. Frank, R. T., 1931. The hormonal causes of premenstrual tension. Archives of Neurology and Psychiatry 26 1053–1057.Google Scholar
  37. Glick, I. D., 1985. Treatment of premenstrual syndrome in psychiatric practice. In H. J. Osofsky and S. J. Blumenthal (Eds.), Premenstrual Syndrome Current Findings and Future Directions. American Psychiatric Press, Washington, D.C., pp. 57–65.Google Scholar
  38. Goldman, A. L., D. Morrison, and L. J. Foster, 1981. Oral progesterone therapy Oxygen in a pill. Archives of International Medicine 141 574–575.CrossRefGoogle Scholar
  39. Gray, L. A., 1941. The use of progesterone in nervous tension states. Southern Medical Journal 34 1004–1006.CrossRefGoogle Scholar
  40. Greenblatt, R. B., 1940. Syndrome of major menstrual moliminà with hypermenorrhea alleviated by testosterone propionate. Journal of the American Medical Association 115 120–124.CrossRefGoogle Scholar
  41. Greene, R. and K. Dalton, 1953. The premenstrual syndrome. British Medical Journal 1 1007–1014.PubMedCrossRefGoogle Scholar
  42. Greep, R., 1977. The genesis of research on the progestins. Annals of the New York Academy of Sciences 286 1–8.PubMedCrossRefGoogle Scholar
  43. Israel, S. L., 1938. Premenstrual tension. Journal of the American Medical Association 110 1721–1723.CrossRefGoogle Scholar
  44. Kalkhoff, R. K., 1982. Metabolic effects of progesterone. American Journal of Obstetrics and Gynecology 142 735–738.PubMedGoogle Scholar
  45. Kapp, M. B., 1981. Prescribing approved drugs for nonapproved uses. Physicians’ disclosure obligations to their patients. Law, Medicine and Health Care ,October, pp. 20–23.Google Scholar
  46. Lane, G., N. C. Siddle, T. A. Ryder, J. Pryse-Davies, R.J.B. King, and M. I. Whitehead, 1983. Dose-dependent effects of oral progesterone on the oestrogenized postmenopausal endometrium. British Medical Journal 287 1241–1245.PubMedCrossRefGoogle Scholar
  47. Macht, D. I., 1943. Further historical and experimental studies on menstrual toxin. American Journal of Medicine & Science ,September, pp. 281–305.Google Scholar
  48. Marker, R., 1947. New sources of sapogenins. Journal of the American Chemical Society 69 2242.PubMedCrossRefGoogle Scholar
  49. Maxson, W. S. and J. T. Hargrove, 1985. Bioavailability of oral micronized progesterone. Fertility and Sterility 44 622–626.PubMedGoogle Scholar
  50. McDonough, P. G., 1985. Progesterone therapy Benefit versus risk. Fertility and Sterility 44 13–16.PubMedGoogle Scholar
  51. McLaughlin, L., 1982. The Pill, John Rock, and the Church. Little, Brown and Co., Boston, MA.Google Scholar
  52. Mishell, D. R., 1982. Noncontraceptive health benefits of oral steroidal contraceptives. American Journal of Obstetrics and Gynecology 142 809.PubMedGoogle Scholar
  53. Moos, R. H., 1968. The development of a menstrual distress questionnaire. Psychosomatic Medicine 30 853–867.PubMedGoogle Scholar
  54. Moos, R. H., 1977. Menstrual Distress Questionnaire Manual Social Ecology Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA.Google Scholar
  55. Morton, J. H., 1950. Premenstrual tension. American Journal of Obstetrics and Gynecology 60 343.PubMedGoogle Scholar
  56. Mukherjee, C., 1954. Premenstrual tension A critical study of the syndrome. Journal of the Indiana Medical Association 24 81–97.Google Scholar
  57. Munday, M. R., M. G. Brush, and R. W. Taylor, 1977. Progesterone and aldosterone levels in premenstrual tension syndrome. Journal of Endocrinology 73 21.CrossRefGoogle Scholar
  58. Munday, M. R., M. G. Brush, and R. W. Taylor, 1981. Correlation between progesterone, oestradiol and aldosterone levels in the premenstrual syndrome. Clinical Endocrinology 14 1–9.PubMedCrossRefGoogle Scholar
  59. Nillius, S. J. and E.D.B. Johansson, 1971. Plasma levels of progesterone after vaginal, rectal, or intramuscular administration of progesterone. American Journal of Obstetrics and Gynecology 110 470–477.PubMedGoogle Scholar
  60. Norris, R. V., 1983. Progesterone for premenstrual tension. Journal of Reproductive Medicine 28 509–516.PubMedGoogle Scholar
  61. Norris, R. V., 1985. Clinical management of the premenstrual tension syndrome. In M. Y. Dawood, J. L. McGuire, and L. M. Demers (Eds.), Premenstrual Syndrome and Dysmenorrhea Urban and Schwarzenberg, Baltimore, MD, pp. 67–76.Google Scholar
  62. Norris, R. V. and C. Sullivan, 1983. PMS Premenstrual Syndrome. Rawson Associates, New York, NY.Google Scholar
  63. Novak, E., 1924. Menstruation and Its Disorders. Appleton, New York, NY.Google Scholar
  64. Ottosson, U. B., B. G. Johansson, and B. von Schoultz, 1985. Subfractions of high-density lipoprotein cholesterol during estrogen therapy A comparison between progestogens and natural progesterone. American Journal of Obstetrics and Gynecology 151 746–750.PubMedGoogle Scholar
  65. Parker, A. S., 1960. The premenstrual tension syndrome. Medical Clinics of North America 44 339–348.PubMedGoogle Scholar
  66. Peterson, D. H., 1952. Microbiological transformation of steroids. Journal of the American Chemical Society 74 5933.CrossRefGoogle Scholar
  67. Pincus, G. and M. C. Chang, 1953. The effects of progesterone and related compounds on ovulation and early development in the rabbit. Acta Physiologica Latinoamericana 3 177–183.Google Scholar
  68. Prenant, A., 1898. La valeur morphologique du corps jaune. Son action physiologique et therapeutique possible. Revue General Science Pure Applied Bulletin Association of France for Advanced Science 9 646–650.Google Scholar
  69. Price, J. H., H. Ismail, R. H. Gorwill, and I. R. Sarda, 1983. Effect of the suppository base on progesterone delivery from the vagina. Fertility and Sterility 39 490–493.PubMedGoogle Scholar
  70. Puech, A., 1942. Menstrual disorder. Montpellier Medicine 21 118.Google Scholar
  71. Rees, L., 1953. The premenstrual tension syndrome and its treatment. British Medical Journal 1 1014–1016.PubMedCrossRefGoogle Scholar
  72. Rozenbaum, H., 1982. Relationships between chemical structure and biological properties of progestogens. American Journal of Obstetrics and Gynecology 142 719–724.PubMedGoogle Scholar
  73. Rubinow, D. R., P. Roy-Byrne, and M. C. Hoban, 1984. Prospective assessment of menstrually related mood disorders. American Journal of Psychiatry 141 684–686.PubMedGoogle Scholar
  74. Ruble, D. N. and J. Brooks-Gunn, 1979. Menstrual symptoms A social cognition analysis. Journal of Behavioral Medicine 2 171–194.PubMedCrossRefGoogle Scholar
  75. Sampson, G. A., 1979. Premenstrual syndrome A double-blind controlled trial of progesterone and placebo. British Journal of Psychiatry 136 209–215.CrossRefGoogle Scholar
  76. Sampson, G. A., 1981. An appraisal of the role of progesterone in the therapy of premenstrual syndrome. In P. A. van Keep and W. H. Utian (Eds.), The Premenstrual Syndrome. MTP Press, Lancaster, England, pp. 51–69.CrossRefGoogle Scholar
  77. Slotta, K. H., H. Raschig, and E. Fels, 1934. Reindarstellung der hormone aus dem corpus luteum. Berichte Chemische Gesellschaft 67 1270–1273.CrossRefGoogle Scholar
  78. Smith, S. L., 1975. Mood and menstrual cycle. In E. J. Sacher (Ed.), Topics in Psychoendocrinology. Grune & Stratton, New York, NY, pp. 19–59.Google Scholar
  79. Smith, S. L., 1976. The menstrual cycle and mood disturbance. Clinical Obstetrics and Gynecology 19 391–397.PubMedCrossRefGoogle Scholar
  80. Smith, S. L., J. M. Cleghorn, D. L. Streiner, and E. V. Younglai, 1975. A study of estrogens and progesterone in premenstrual depression. In The Family. 4th International Congress of Psychosomatic Obstetrics and Gynecology, Tel Aviv. Karger, Basel, pp. 538–542.Google Scholar
  81. Spodick, D. H., 1982. The randomized controlled clinical trial Scientific and ethical bases. American Journal of Medicine 73 420–425.PubMedCrossRefGoogle Scholar
  82. Stage, S., 1979. Female Complaints Lydia Pinkham and the Business of Women’s Medicine. W. W. Norton, New York, NY.Google Scholar
  83. Today Show, 1981. NBC Television, November 20.Google Scholar
  84. Toufexis, A., J. C. Simpson, and S. Wymelenberg, 1981. Coping with Eve’s curse. Time ,July 27, p. 59.Google Scholar
  85. Waxman, D., 1968. Progesterone and premenstrual tension syndrome. British Medical Journal 4 188.CrossRefGoogle Scholar
  86. Whitehead, M. I., P. T. Townsend, D. K. Gill, W. P. Collins, and S. Campbell, 1980. Absorption and metabolism of oral progesterone. British Medical Journal 280 825–828.PubMedCrossRefGoogle Scholar
  87. Widholm, O., M. Frisk, and T. Tenhunen, 1967. Gynecological findings in adolescence. Acta Obstetrica and Gynecologica Scandinavica (Suppl. 1) 46 1–7.Google Scholar
  88. Wintersteiner, O. and W. M. Allen, 1934. Crystalline progestin. Journal of Biological Chemistry 107 321–336.Google Scholar
  89. Witzman, R. F., 1981. Steroids. Van Nostrand Reinhold, New York, NY.Google Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • Ronald V. Norris
    • 1
  1. 1.Healthcare Services of America, Inc.BirminghamUSA

Personalised recommendations